Glivec

Syndicate content

Showdown for big pharma in Supreme Court

novartis.jpg.crop_display.jpg

The Supreme Court will hear final arguments in a landmark case over drug patents that could change the rules for the country's healthcare sector and potentially curb its global role as a supplier of c

No Articles Found

No Articles Found

No Articles Found

I want to begin with a little story that was told to me by a leading executive at Aptech. He was exercising in a gym with a lot of younger people.

Shekhar Kapur’s Bandit Queen didn’t make the cut. Neither did Shaji Karun’s Piravi, which bagged 31 international awards.